M Alonso-Alonso, F Ziemke, F Magkos… - … American Journal of …, 2011 - Am Soc Nutrition 1 From the Division of Endocrinology, Diabetes and Metabolism (FZ, FM, MB, IB, AR-G, MY, CSM), the Division of Cognitive Neurology (MA-A and AP-L), and the Department of Radiology (RR), Beth Israel Deaconess Medical Center, and the Section of Endocrinology, Boston ... Related articles - All 2 versions
C Blockeel, MD Sterrenburg… - Journal of Clinical …, 2011 - Endocrine Soc Address all correspondence and requests for reprints to: Christophe Blockeel, Centre for Reproductive Medicine, UZ Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium. E-mail: christophe.blockeel{at}uzbrussel.be. ... ↵* CB and MDS contributed equally to this work. Cited by 1 - Related articles - All 3 versions
C Blockeel, I Van Vaerenbergh… - Molecular human …, 2011 - Oxford Univ Press The past decade has seen growing interest in ovarian stimulation protocols with GnRH antagonists in an effort to reduce the incidence of potential complications, such as cyst formation and ovarian hyperstimulation syndrome, and thus improve the clinical experience for patients. Current ... Related articles - All 5 versions
[HTML] from medwelljournals.comL Chen, K Yi, Y Sun, Y Sun… - Journal of Animal and …, 2011 - medwelljournals.com Abstract: Neurotrophins (NTs) belong to a family of soluble homodimeric polypeptide growth factors and are widely recognized for their essential roles in central and peripheral nervous systems. One such neurotrophin, Brain-Derived Neurotrophic Factor (BDNF) was ... Cached
E Labarta, JA Martínez-Conejero, P Alamá… - Human …, 2011 - ESHRE METHODS For this prospective cohort study, microarray data were obtained from endometrial biopsies from 12 young healthy oocyte donors undergoing COS with pituitary suppression by either gonadotrophin-releasing hormone (GnRH) agonists or antagonists, and ... Cited by 2 - Related articles - All 4 versions